FDA Approves Theranica’s Nerivio® for Acute Treatment of Migraine in Adolescents
The Prescribed Wearable Device is Now indicated for Patients 12 Years Old and Above Theranica, a prescribed digital therapeutics (PDT) company developing advanced electroceuticals for migraine and other pain conditions, today announced that its Nerivio® therapeutic device has received…